Nautilus Biotechnology, Inc. (NAUT) NASDAQ
3.31
-0.05(-1.49%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
3.31
-0.05(-1.49%)
Currency In USD
| Market Cap | 246.2M |
| Enterprise Value | 263.83M |
| P/E Ratio | -7.07 |
| PEG Ratio | -1.18 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 2.66 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -8.3 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.31 |
| Return On Equity | -0.34 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -6.47M |
| EBITDA | -52.54M |
| Net Income | -59M |
| Diluted EPS | -0.47 |
| Total Cash | 103.41M |
| Total Cash/Share | 0.82 |
| Total Debt | 30.02M |
| Total Debt/Equity | 0.19 |
| Current Ratio | 13.33 |
| Book Value Per Share | 1.24 |
| 52-Week Change | 340.08 |
| 52-Week High | 4.31 |
| 52-Week Low | 0.62 |
| Moving Average 50 Days | 2.61 |
| Moving Average 200 Days | 1.58 |
| Average Volume | 276,801 |
| Shares Outstanding | 126.56M |
| % Held by Institutions | 46.19 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |